El cáncer es mucho más complejo de lo que imaginábamos .

Cancer de Amigdalas , sexo oral frecuente aumenta el riesgo .

Aplidin Patente del DANA FARBER CANCER INST INC (US), en Multiple Myeloma .

APLIDINE FOR MULTIPLE MYELOMA TREATMENT.

Publication number: MXPA05009742
Publication date: 2006-05-25
Inventor: MITSIADES NICHOLAS (US)
Applicant: DANA FARBER CANCER INST INC (US)
Classification:
- international: A61K38/15; A61P35/00; A61K38/15; A61P35/00; (IPC1-7): A61K38/15; A61P35/00
- european: A61K38/15
Application number: MX2005PA09742 20050912
Priority number(s): US20030454125P 20030312; US20030520293P 20031114; WO2004GB01062 20040312

Abstract of MXPA05009742

Aplidine and aplidine analogues are used in the manufacture of a medicament for treating multiple myeloma.

Aplidin en EEUU consigue Patente en Tratamiento Leucemia / Lymphoma y en Terapias combinatorias .

Antitumoral treatments

Publication number: US2006178298
Publication date: 2006-08-10
Inventor: BERTINO JOSEPH R (US); BARNEJEE DEBABRATA (US); GURAY SAYDAM (US); JIMENO JOSE (ES); FAIRCLOTH GLYNN T (US)
Applicant:
Classification:
- international: A61K38/12; A61K38/12;
- european:
Application number: US20050546750 20051104
Priority number(s): US20030454125P 20030312; WO2004US07606 20040312; US20050546750 20051104

Abstract of US2006178298

Aplidine and aplidine analogues are of use for the treatment of cancer, in particular in the treatment of leukemias and lymphomas, especially in combination therapies.